Mark Cuban: Why You're Overpaying for Prescriptions – and Who's Pocketing the Difference

Mark Cuban did not set out to become the most disruptive force in American drug pricing. He just wanted to know why the same generic pill could cost $15 at one pharmacy and $500 at another. In this episode of Value Health Voices, Mark tells Dr. Anthony Paravati and Dr. Amar Rewari exactly what he found when he peered under the hood of the pharmacy supply chain, and why his answer was to launch Cost Plus Drugs with a radically simple promise: show patients the real cost, add a fair markup, and sell trust instead of marketing.

The conversation goes deep into the machinery most patients never see. Mark breaks down how pharmacy benefit managers profit from rebates, spread pricing, and formulary threats, why brand manufacturers privately admit they cannot work with him, and how vertically integrated conglomerates shuffle billions between their own subsidiaries. He shares the story of a heart transplant patient whose life depended on a $200 generic her employer's plan refused to cover, and explains why he now spends his time telling CEOs to run their PBM contracts through AI and ask one question: where am I getting ripped off?

Mark also lays out his blueprint for reform, including deductible credit for cash purchases, real consequences for repeat offenders, federally guaranteed healthcare loans, and full contract transparency. He makes the case for direct contracting between hospitals and self-insured employers, explains why he believes real change comes from outside Washington, and settles the question everyone keeps asking: whether he will run for president. This is a candid, unfiltered look at the business of American healthcare from the one outsider who decided to fix it himself.

Episode Resources:

Mark Cuban’s Cost Plus Drug CompanyCost Plus Wellness for Self-Insured EmployersJAMA Study on Potential Savings via Cost Plus Drugs